Detalhe da pesquisa
1.
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.
J Immunol
; 204(8): 2295-2307, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179637
2.
Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapies.
Semin Cancer Biol
; 61: 11-22, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31546009
3.
TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin.
Mol Pharmacol
; 100(2): 144-154, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031188
4.
Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.
J Transl Med
; 19(1): 43, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485341
5.
Subcellular Localization and Activity of the Mitogen-Activated Protein Kinase Kinase 7 (MKK7) γ Isoform are Regulated through Binding to the Phosphatase Calcineurin.
Mol Pharmacol
; 95(1): 20-32, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30404891
6.
Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines.
Mol Pharmacol
; 96(6): 862-870, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554698
7.
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.
Mol Cancer
; 17(1): 60, 2018 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458371
8.
Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data.
Bioinformatics
; 31(23): 3799-806, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206305
9.
An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer.
BMC Genomics
; 16 Suppl 12: S2, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681397
10.
Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.
Bioinformatics
; 30(17): 2393-8, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24812339
11.
A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines.
Mol Pharmacol
; 83(4): 882-93, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23371912
12.
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.
Mod Pathol
; 26(10): 1298-306, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23619603
13.
Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models.
Front Oncol
; 13: 1094123, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36845684
14.
A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes.
bioRxiv
; 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066347
15.
A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes.
Biol Open
; 12(8)2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470475
16.
Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response.
Cancer Lett
; 556: 216062, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657561
17.
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity.
NPJ Precis Oncol
; 7(1): 15, 2023 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739466
18.
EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.
Nat Commun
; 13(1): 3535, 2022 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725568
19.
Upregulation of complement proteins in lung cancer cells mediates tumor progression.
Front Oncol
; 12: 1045690, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36686777
20.
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
NPJ Precis Oncol
; 5(1): 41, 2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001994